# A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

> **NCT03152318** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 62 (estimated)

## Conditions studied

- Malignant Glioma of Brain
- Astrocytoma
- Malignant Astrocytoma
- Oligodendroglioma
- Anaplastic Oligodendroglioma of Brain (Diagnosis)
- Mixed Oligo-Astrocytoma
- Ependymoma
- Ganglioglioma
- Pylocytic/Pylomyxoid Astrocytoma
- Brain Tumor
- Glioma
- Brain Cancer
- Glioblastoma
- Glioblastoma Multiforme

## Interventions

- **DRUG:** rQNestin
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Stereotactic biopsy

## Key facts

- **NCT ID:** NCT03152318
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-07-18
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152318, "A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03152318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*